NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number

国药准字H20223047

Company扬州中宝药业股份有限公司

Registration Date

January 30, 2022

Drug Information

Generic Name

盐酸左沙丁胺醇雾化吸入溶液

Dosage Form

吸入制剂

Strength

3ml：0.63mg（按C13H21NO3计）

Drug Type

化学药品

Registration Date

January 30, 2022

Company Information

Applicant Company

Company Name扬州中宝药业股份有限公司

Company Address

江苏省扬州市宝应县经济开发区新区宝应大道91号

Manufacturing Company

Company Name扬州中宝药业股份有限公司

Company Address

江苏省扬州市宝应县经济开发区新区宝应大道91号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸左沙丁胺醇雾化吸入溶液 - NMPA 批准文号 | MedPath